Adjuvant transarterial chemoembolization following radical resection for intrahepatic cholangiocarcinoma: A multi-center retrospective study
暂无分享,去创建一个
Weiping Zhou | Ziguo Lin | J. Lou | X. Bi | Jingdong Li | Fuyu Li | Ya-min Zheng | Lei Wang | Jianming Wang | Jian Wang | Shu-guo Zheng | Q. Ke | W. Guo | Y. Zeng | S. Cheng | Weiping Zhou
[1] Jingfeng Liu,et al. Does postoperative adjuvant transarterial chemoembolization benefit for all patients with hepatocellular carcinoma combined with microvascular invasion: a meta-analysis , 2019, Scandinavian journal of gastroenterology.
[2] T. Pawlik,et al. Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma , 2019, Annals of Surgical Oncology.
[3] F. Shen,et al. [Progress on surgical treatment of intrahepatic cholangiocarcinoma]. , 2019, Zhonghua wai ke za zhi [Chinese journal of surgery].
[4] W. Lau,et al. Postoperative Adjuvant Transarterial Chemoembolization Improves Outcomes of Hepatocellular Carcinoma Associated with Hepatic Vein Invasion: A Propensity Score Matching Analysis , 2019, Annals of Surgical Oncology.
[5] Ya Cao,et al. Systemic inflammation score predicts survival in patients with intrahepatic cholangiocarcinoma undergoing curative resection , 2019, Journal of Cancer.
[6] D M Parkin,et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods , 2018, International journal of cancer.
[7] R. Martino,et al. Resection for intrahepatic cholangiocellular cancer: new advances. , 2018, Translational gastroenterology and hepatology.
[8] T. Pawlik,et al. Trends in use of lymphadenectomy in surgery with curative intent for intrahepatic cholangiocarcinoma , 2018, The British journal of surgery.
[9] T. Pawlik,et al. Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent , 2018, The British journal of surgery.
[10] Zhao-You Tang,et al. Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study , 2018, Clinical Cancer Research.
[11] T. Pawlik,et al. Preoperative Risk Score and Prediction of Long-Term Outcomes after Hepatectomy for Intrahepatic Cholangiocarcinoma. , 2017, Journal of the American College of Surgeons.
[12] Q. Xia,et al. Transarterial Chemoembolization: A Favorable Postoperative Management to Improve Prognosis of Hepatitis B Virus-associated Intrahepatic Cholangiocarcinoma after Surgical Resection , 2017, International journal of biological sciences.
[13] W. Lau,et al. Actual over 10-year survival after liver resection for patients with intrahepatic cholangiocarcinoma , 2017, Oncotarget.
[14] Han Zhang,et al. Surgical options for intrahepatic cholangiocarcinoma. , 2017, Hepatobiliary surgery and nutrition.
[15] J. Geschwind,et al. Intra-arterial embolotherapy for intrahepatic cholangiocarcinoma: update and future prospects. , 2017, Hepatobiliary surgery and nutrition.
[16] J. Sicklick,et al. NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.
[17] S. Qiu,et al. Serum gamma-glutamyl transferase levels affect the prognosis of patients with intrahepatic cholangiocarcinoma who receive postoperative adjuvant transcatheter arterial chemoembolization: A propensity score matching study. , 2017, International journal of surgery.
[18] M. Gönen,et al. Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone , 2016, Cancer.
[19] M. Miyazaki,et al. Intrahepatic cholangiocarcinoma: expert consensus statement. , 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[20] Dong-hao Wu,et al. Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification. , 2015, The oncologist.
[21] F. Johnston,et al. Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma , 2015, Journal of surgical oncology.
[22] A. Ejaz,et al. Temporal trends in liver‐directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: A population‐based analysis , 2014, Journal of surgical oncology.
[23] Q. Ye,et al. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection , 2014, Liver international : official journal of the International Association for the Study of the Liver.
[24] Elizabeth A Stuart,et al. Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research. , 2013, Journal of clinical epidemiology.
[25] Kui Wang,et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] N. Yang,et al. Postoperative adjuvant transcatheter arterial chemoembolisation improves survival of intrahepatic cholangiocarcinoma patients with poor prognostic factors: results of a large monocentric series. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[27] M. Kendrick,et al. Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database. , 2011, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[28] Jiamei Yang,et al. Adjuvant Transcatheter Arterial Chemoembolization for Intrahepatic Cholangiocarcinoma after Curative Surgery: Retrospective Control Study , 2011, World Journal of Surgery.
[29] Q. Ye,et al. Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma , 2009, Journal of Cancer Research and Clinical Oncology.
[30] W. Jarnagin,et al. Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. , 2001, Journal of the American College of Surgeons.